McKesson Corporation (MCK) Earnings Call Analysis
NYSE · Healthcare · Medical Distribution
Next earnings call: 2026-08-05
(Q1 2027)
— full calendar
Earnings Reports
-
McKesson (MCK) Q3 2026: Oncology and Biopharma Drive 37% Segment Surge, Portfolio Realignment Accelerates
June 15, 2026
-
McKesson (MCK) Q4 2026: Oncology and Multi-Specialty Profit Jumps 53% as Platform Scale Accelerates
May 08, 2026
-
McKesson (MCK) Q2 2026: Oncology and Multispecialty Profit Surges 71% as Platform Expansion Accelerates
November 06, 2025
-
McKesson (MCK) Q1 2026: Specialty Pharma and GLP-1 Drive 25% U.S. Revenue Surge
August 06, 2025
-
McKesson (MCK) Q4 2025: Oncology Platform Adds 725 Providers, Driving Strategic Margin Expansion
June 30, 2025